INHIBITEURS D'IP6K

• 收藏
• 分享

专利权人:

Takeda Pharmaceutical Company Limited

发明人:

申请号：

EP18723386.1

公开号：

EP3601256A1

申请日:

2018.03.29

申请国别(地区):

EP

年份:

2020

代理人:

摘要：

The present invention aims to provide a heterocyclic compound having an IP6K inhibitory action and expected to be useful as a prophylactic or therapeutic agent for- diseases such as cardiac failure, diabetes and the like. A compound represented by the formula (I) : wherein each symbol is as defined in the SPECIFICATION, or a salt thereof has an IP6K inhibitory action and is expected to be useful as a prophylactic or therapeutic agent for diseases such as cardiac failure, diabetes and the like.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/